Absence of follicular phase defect in women with recurrent miscarriage

Fertility and Sterility

Volumn 85, Issue 6, 2006, Pages 1784-1790

  Prakash, Alka ^a   Li, Tin C ^a   Laird, Susan ^a,b   Nargund, Geeta ^c   Ledger, William L ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Biochemistry; follicular phase; recurrent miscarriage

Indexed keywords

BIOCHEMICAL MARKER; FOLLITROPIN; HYPOPHYSIS HORMONE; INHIBIN B; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; PROGESTERONE;

ADULT; ANAMNESIS; ARTICLE; CASE CONTROL STUDY; CLINICAL OBSERVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DOPPLER FLOWMETRY; ENDOMETRIUM; EXPECTATION; FEEDBACK SYSTEM; FEMALE; FOLLICULAR PHASE; FUNCTIONAL ASSESSMENT; HORMONE BLOOD LEVEL; HUMAN; MENSTRUATION DISORDER; OOCYTE; OVARY FOLLICLE DEVELOPMENT; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY; RECURRENT ABORTION; REGULATORY MECHANISM; SPONTANEOUS ABORTION; TERTIARY HEALTH CARE; ULTRASOUND; UNITED KINGDOM; UTERUS BLOOD FLOW;

ABORTION, HABITUAL; ADULT; BIOLOGICAL MARKERS; COMORBIDITY; FEMALE; FOLLICULAR PHASE; GREAT BRITAIN; HORMONES; HUMANS; MENSTRUATION DISTURBANCES; OVARIAN DISEASES; OVARIAN FOLLICLE; STATISTICS;

EID: 33744521237     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2005.11.045     Document Type: Article

References (27)

1. Massague J. The transforming growth factor-beta family. Annu Rev Cell Biol 6 (1990) 597-641
2. Groome N.P., Illingworth P.J., O'Brien M., Pai R., Rodger F.E., Mather J.P., et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 81 (1996) 1401-1405
3. Kwee J., Elting M.W., Schats R., Bezemer P.D., Lambalk C.B., and Schoemaker J. Comparison of endocrine tests with respect to their predictive value on the outcome of ovarian hyperstimulation in IVF treatment. results of a prospective randomized study. Hum Reprod 18 (2003) 1422-1427
4. Josso N., Legeai L., Forest M.G., Chaussain J.L., and Brauner R. An enzyme linked immunoassay for anti-mullerian hormone. a new tool for the evaluation of testicular function in infants and children. J Clin Endocrinol Metab 70 (1990) 23-27
5. Durlinger A.L., Kramer P., Karels B., de Jong F.H., Uilenbroek J.T., Grootegoed J.A., et al. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 140 (1999) 5789-5796
6. de Vet A., Laven J.S., de Jong F.H., Themmen A.P., and Fauser B.C. Antimullerian hormone serum levels. a putative marker for ovarian aging. Fertil Steril 77 (2002) 357-362
7. Fanchin R., Schonauer L.M., Righini C., Guibourdenche J., Frydman R., and Taieb J. Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 18 (2003) 323-327
8. Lass A., Gerrard A., Abusheikha N., Akagbosu F., and Brinsden P. IVF performance of women who have fluctuating early follicular FSH levels. J Assist Reprod Genet 17 (2000) 566-573
9. Kligman I., and Rosenwaks Z. Differentiating clinical profiles. predicting good responders, poor responders, and hyperresponders. Fertil Steril 76 (2001) 1185-1190
10. Frattarelli J.L., Bergh P.A., Drews M.R., Sharara F.I., and Scott R.T. Evaluation of basal estradiol levels in assisted reproductive technology cycles. Fertil Steril 74 (2000) 518-524
11. Vazquez M.E., Verez J.R., Stern J.J., Gutierrez Najar A., and Asch R.H. Elevated basal estradiol levels have no negative prognosis in young women undergoing ART cycles. Gynecol Endocrinol 12 (1998) 155-159
12. Gonen Y., Casper R.F., Jacobson W., and Blankier J. Endometrial thickness and growth during ovarian stimulation. a possible predictor of implantation in in vitro fertilization. Fertil Steril 52 (1989) 446-450
13. Glissant A., de Mouzon J., and Frydman R. Ultrasound study of the endometrium during in vitro fertilization cycles. Fertil Steril 44 (1985) 786-790
14. Steer C.V., Campbell S., Pampiglione J.S., Kingsland C.R., Mason B.A., and Collins W.P. Transvaginal colour flow imaging of the uterine arteries during the ovarian and menstrual cycles. Hum Reprod 5 (1990) 391-395
15. Habara T., Nakatsuka M., Konishi H., Asagiri K., Noguchi S., and Kudo T. Elevated blood flow resistance in uterine arteries of women with unexplained recurrent pregnancy loss. Hum Reprod 17 (2002) 190-194
16. Li T.C., Spuijbroek M.D., Tuckerman E., Anstie B., Loxley M., and Laird S. Endocrinological and endometrial factors in recurrent miscarriage. Br J Obstet Gynaecol 107 (2000) 1471-1479
17. Shimada S., Kato E.H., Morikawa M., Iwabuchi K., Nishida R., Kishi R., et al. No difference in natural killer or natural killer T-cell population, but aberrant T-helper cell population in the endometrium of women with repeated miscarriage. Hum Reprod 19 (2004) 1018-1024
18. Tulppala M., Bjorses U.M., Stenman U.H., Wahlstrom T., and Ylikorkala O. Luteal phase defect in habitual abortion. progesterone in saliva. Fertil Steril 56 (1991) 41-44
19. Klinkert E.R., Broekmans F.J., Looman C.W., Habbema J.D., and te Velde E.R. The antral follicle count is a better marker than basal follicle-stimulating hormone for the selection of older patients with acceptable pregnancy prospects after in vitro fertilization. Fertil Steril 83 (2005) 811-814
20. Ozaki T., Hata K., Xie H., Takahashi K., and Miyazaki K. Utility of color Doppler indices of dominant follicular blood flow for prediction of clinical factors in in vitro fertilization-embryo transfer cycles. Ultrasound Obstet Gynecol 20 (2002) 592-596
21. Nargund G. Time for an ultrasound revolution in reproductive medicine. Ultrasound Obstet Gynecol 20 (2002) 107-111
22. Schild R.L., Holthaus S., d'Alquen J., Fimmers R., Dorn C., van der Ven H., et al. Quantitative assessment of subendometrial blood flow by three-dimensional-ultrasound is an important predictive factor of implantation in an in-vitro fertilization programme. Hum Reprod 15 (2000) 89-94
23. Cheung W., Ng E.H.Y., and Ho P.C. A randomized double-blind comparison of perifollicular vascularity and endometrial receptivity in ovulatory women taking clomiphene citrate at two different times. Hum Reprod 17 (2002) 2881-2884
24. Chui D., Pugh N., Walker S., Gregory L., and Shaw R. Follicular vascularity-the predictive value of transvaginal power Doppler ultrasonography in an in-vitro fertilization programme. a preliminary study. Hum Reprod 12 (1997) 191-196
25. Durlinger A.L., Gruijters M.J., Kramer P., Karels B., Kumar T.R., Matzuk M.M., et al. Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142 (2001) 4891-4899
26. Lyet L., Louis F., Forest M.G., Josso N., Behringer R.R., and Vigier B. Ontogeny of reproductive abnormalities induced by deregulation of anti-mullerian hormone expression in transgenic mice. Biol Reprod 52 (1995) 444-454
27. Muttukrishna S., Jauniaux E., Greenwold N., McGarrigle H., Jivraj S., Carter S., et al. Circulating levels of inhibin A, activin A and follistatin in missed and recurrent miscarriages. Hum Reprod 17 (2002) 3072-3078